HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on IN8bio (NASDAQ:INAB) and maintained a $14 price target.
August 11, 2023 | 11:25 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a 'Buy' rating on IN8bio and maintained a $14 price target, which could potentially boost investor confidence in the stock.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for IN8bio. The maintained price target of $14 also indicates the firm's continued confidence in the stock's potential, which could positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100